MESENTERIC ARTERIOSCLEROSIS

This adverse event was reported 23 times

These drugs are most commonly taken by patients reporting MESENTERIC ARTERIOSCLEROSIS:

# Drug Count
0 METHOTREXATE 3
1 METHOTREXATE SODIUM 3
2 PANTOPRAZOLE SODIUM 3
3 ALBUTEROL SULFATE 2
4 ASPIRIN 2
5 ASPIRIN 325 MG 2
6 ASPIRIN 81 MG 2
7 CANDESARTAN CILEXETIL 2
8 CARBAMAZEPINE 2
9 CLOPIDOGREL 2
See all common drugs associated with MESENTERIC ARTERIOSCLEROSIS

MESENTERIC ARTERIOSCLEROSIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ETHACRYNIC ACID 1 0.0018
1 STANDARDIZED SENNA CONCENTRATE AND DOCUSATE SODIUM 1 0.0007
2 RIFABUTIN 1 0.0004
3 DOPAMINE HYDROCHLORIDE 1 0.0003
4 CLINDAMYCIN PHOSPHATE 1 0.0002
5 PANCRELIPASE LIPASE, PANCRELIPASE PROTEASE, PANCRELIPASE AMYLASE 1 0.0002
6 PIROXICAM 1 0.0002
7 NABUMETONE 1 0.0002
8 BASILIXIMAB 1 0.0001
9 EMICIZUMAB 1 0.0001
See all drugs enriched for association with MESENTERIC ARTERIOSCLEROSIS

MESENTERIC ARTERIOSCLEROSIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Rifamycin Antimycobacterial [EPC] 1 0.0003
1 Aluminum Complex [EPC] 1 0.0000
2 Antimycobacterial [EPC] 1 0.0000
3 Thiazide-like Diuretic [EPC] 1 0.0000
4 Protease Inhibitor [EPC] 1 0.0000
5 Muscle Relaxant [EPC] 1 0.0000
6 Macrolide Antimicrobial [EPC] 1 0.0000
7 Erythropoiesis-stimulating Agent [EPC] 1 0.0000
8 Complement Inhibitor [EPC] 1 0.0000
9 Cytochrome P450 3A Inhibitor [EPC] 1 0.0000
See all drug classes enriched for association with MESENTERIC ARTERIOSCLEROSIS